Enhanced skin permeation of diclofenac by ion-pair formation and further enhancement by microemulsion

Chemical and Pharmaceutical Bulletin

Volumn 55, Issue 3, 2007, Pages 368-371

  Kamal, Mohammad Abu Hena Mostofa ^a   Iimura, Nahoko ^a   Nabekura, Tomohiro ^a   Kitagawa, Shuji ^b  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Diclofenac; Ion pair; Microemulsion; Skin permeation

Indexed keywords

ALCOHOL; ALIPHATIC AMINE; AMINE; BENZYLAMINE; DICLOFENAC; HEXYLAMINE; ISO OCTYLAMINE; MYRISTIC ACID ISOPROPYL ESTER; PHOSPHATE BUFFERED SALINE; POLYSORBATE 80; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG TRANSPORT; EMULSION; GUINEA PIG; ION CURRENT; ION PAIR EXTRACTION; MALE; NONHUMAN; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; DICLOFENAC; EMULSIONS; GUINEA PIGS; IONS; MALE; MYRISTATES; PERMEABILITY; SKIN ABSORPTION;

EID: 34047167903     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.55.368     Document Type: Article

References (20)

1. Megwa S. A., Cross S. E., Whitehouse M. W., Benson H. A. E., Roberts M. S., J. Pharm. Pharmacol., 52, 929-940 (2000).
2. Kamal M. A. H. M., Iimura N., Nabekura T., Kitagawa S., Chem. Pharm. Bull., 54, 481-484 (2006).
3. Menasse R., Hedwall P. R., Kraetz J., Pericin C., Riester L., Sallmann A., Ziel R., Jaque R., Scand. J. Rheumatol., 22 (Suppl.), 5-16 (1978).
4. Nishihata T., Kotera K., Nakano Y., Yamazaki M., Chem. Pharm. Bull., 35, 3807-3812 (1987).
5. Kitagawa S., Hosokai A., Kaseda Y., Yamamoto N., Kaneko Y., Matsuoka E., Int. J. Pharmaceut., 161, 115-122 (1998).
6. Gallarate M., Gasco M. R., Trotta M., Acta Pharm. Technol., 34, 102-105 (1988).
7. Iwamoto K., Kato T., Kawahara M., Koyama N., Watanabe S., Miyake Y., Sunamoto J., J. Pharm. Sci., 80, 219-224 (1991).
8. Kreilgaard M., Adv. Drug Deliv. Rev., 54 (Suppl.), S77-S98 (2002).
9. Fevrier F., Bobin M. F., Lafforgue C., Martini M. C., S. T. P. Pharm. Sci., 1, 60-63 (1991).
10. Kemken J., Ziegler A., Mueller B. W., J. Pharm. Pharmacol., 43, 679-684 (1991).
11. Begona D.-C. M., Iglesias-Vilas G., Blanco-Mendez J., Arturo L.-Q. M., Marty J. P., Guy R. H., Eur. J. Pharm. Biopharm., 43, 37-42 (1997).
12. Rhee Y.-S., Choi J.-G., Park E.-S., Chi S.-C., Int. J. Pharmaceut., 228, 161-170 (2001).
13. Peltola S., Saarinen-Savolainen P., Kiesvaara J., Suhonen T. M., Urtti A., Int. J. Pharmaceut., 254, 99-107 (2003).
14. Laurence M. Y., Rees G. D., Adv. Drug Deliv. Rev., 45, 89-121 (2000).
15. Lee P. J., Langer R., Shastri V. P., Pharm. Res., 20, 264-269 (2003).
16. Kitagawa S., Yokochi N., Murooka N., Int. J. Pharmaceut., 126, 49-56 (1995).
17. Nash R. A., Mehta D. B., Matias J. R., Orentreich N., Skin Pharmacol., 5, 160-170 (1992).
18. Gao S., Sing J., Int. J. Pharmaceut., 165, 45-55 (1998).
19. Aungst B. J., Rogers N. J., Shefter E., Int. J. Pharmacet., 33, 225-234 (1986).
20. Kweon J.-H., Chi S.-C., Park E.-S., Arch. Pharm. Res., 27, 351-356 (2004).